Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
911.98
802.80
624.80
407.86
233.39
115.38
82.05
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
911.98
802.80
624.80
407.86
233.39
115.38
82.05
Raw Material Cost
133.22
122.99
96.58
66.11
33.28
17.62
13.64
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.14
0.02
0.00
1.68
2.13
2.12
2.12
Selling and Distribution Expenses
624.64
529.61
451.96
320.69
202.62
127.87
90.47
Other Expenses
10.30
11.41
11.65
6.70
3.52
2.40
1.07
Total Expenditure (Excl Depreciation)
861.03
766.72
665.07
455.45
273.24
171.59
116.95
Operating Profit (PBDIT) excl Other Income
51
36.1
-40.300000000000004
-47.599999999999994
-39.900000000000006
-56.2
-34.900000000000006
Other Income
18.93
22.39
20.36
5.00
0.01
1.24
3.81
Operating Profit (PBDIT)
83.84
65.02
-17.06
-39.69
-37.85
-53.16
-29.68
Interest
0.14
0.02
0.00
1.68
2.13
2.12
2.12
Exceptional Items
-4.05
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
778.76
679.82
528.22
341.74
200.12
97.76
68.41
Depreciation
13.96
6.55
2.85
2.90
1.99
1.81
1.40
Profit Before Tax
65.70
58.45
-19.91
-44.27
-41.97
-57.09
-33.20
Tax
-79.72
4.94
1.25
0.61
0.07
0.12
0.04
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
145.42
53.51
-21.15
-44.88
-42.04
-57.20
-33.24
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
145.42
53.51
-21.15
-44.88
-42.04
-57.20
-33.24
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
145.42
53.51
-21.15
-44.88
-42.04
-57.20
-33.24
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
781.16
689.70
572.51
496.01
229.05
229.75
139.84
Earnings per share (EPS)
4.89
1.75
-0.72
-1.6
-1.54
-2.19
-1.4
Diluted Earnings per share
4.89
1.75
-0.72
-1.6
-1.54
-2.19
-1.4
Operating Profit Margin (Excl OI)
5.59%
4.49%
-6.45%
-11.67%
-17.07%
-48.72%
-42.53%
Gross Profit Margin
8.73%
8.1%
-2.73%
-10.14%
-17.13%
-47.91%
-38.76%
PAT Margin
15.95%
6.67%
-3.39%
-11.0%
-18.01%
-49.58%
-40.52%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 13.60% vs 28.49% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 171.78% vs 352.36% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 52.35% vs 213.90% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Inspire Medical Systems, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
911.98
5,101.00
-4,189.02
-82.12%
Other Operating Income
0.00
0.00
0.00
Total Operating income
911.98
5,101.00
-4,189.02
-82.12%
Raw Material Cost
133.22
2,308.00
-2,174.78
-94.23%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.14
431.00
-430.86
-99.97%
Selling and Distribution Expenses
624.64
2,234.00
-1,609.36
-72.04%
Other Expenses
10.30
-6.00
16.30
271.67%
Total Expenditure (Excl Depreciation)
861.03
4,913.00
-4,051.97
-82.47%
Operating Profit (PBDIT) excl Other Income
50.95
188.00
-137.05
-72.90%
Other Income
18.93
28.00
-9.07
-32.39%
Operating Profit (PBDIT)
83.84
637.00
-553.16
-86.84%
Interest
0.14
431.00
-430.86
-99.97%
Exceptional Items
-4.05
-102.00
97.95
96.03%
Gross Profit (PBDT)
778.76
2,793.00
-2,014.24
-72.12%
Depreciation
13.96
421.00
-407.04
-96.68%
Profit Before Tax
65.70
-317.00
382.70
120.73%
Tax
-79.72
35.00
-114.72
-327.77%
Provisions and contingencies
0
0
0.00
Profit After Tax
145.42
-360.00
505.42
140.39%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
145.42
-360.00
505.42
140.39%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
8.00
-8.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
145.42
-352.00
497.42
141.31%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
781.16
6,448.00
-5,666.84
-87.89%
Earnings per share (EPS)
4.89
-1.02
5.91
579.41%
Diluted Earnings per share
4.89
-1.02
5.91
579.41%
Operating Profit Margin (Excl OI)
5.59%
3.69%
0.00
1.90%
Gross Profit Margin
8.73%
2.04%
0.00
6.69%
PAT Margin
15.95%
-7.06%
0.00
23.01%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 91.20 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 13.60% vs 28.49% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 14.54 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 171.78% vs 352.36% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.49 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 52.35% vs 213.90% in Dec 2024
Annual - Interest
Interest 0.01 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.59%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






